Interparfums (IPAR) Competitors $120.68 +2.18 (+1.84%) Closing price 04:00 PM EasternExtended Trading$120.67 -0.01 (-0.01%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IPAR vs. CELH, COTY, ELF, LW, MED, NUS, POST, PBH, HLF, and USNAShould you be buying Interparfums stock or one of its competitors? The main competitors of Interparfums include Celsius (CELH), Coty (COTY), e.l.f. Beauty (ELF), Lamb Weston (LW), Medifast (MED), Nu Skin Enterprises (NUS), Post (POST), Prestige Consumer Healthcare (PBH), Herbalife (HLF), and USANA Health Sciences (USNA). Interparfums vs. Its Competitors Celsius Coty e.l.f. Beauty Lamb Weston Medifast Nu Skin Enterprises Post Prestige Consumer Healthcare Herbalife USANA Health Sciences Interparfums (NASDAQ:IPAR) and Celsius (NASDAQ:CELH) are related companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, media sentiment, institutional ownership, valuation, earnings and analyst recommendations. Do analysts recommend IPAR or CELH? Interparfums presently has a consensus price target of $162.00, indicating a potential upside of 34.24%. Celsius has a consensus price target of $47.83, indicating a potential upside of 11.92%. Given Interparfums' stronger consensus rating and higher possible upside, research analysts clearly believe Interparfums is more favorable than Celsius.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Interparfums 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Celsius 1 Sell rating(s) 3 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.72 Which has more risk and volatility, IPAR or CELH? Interparfums has a beta of 1.43, suggesting that its share price is 43% more volatile than the S&P 500. Comparatively, Celsius has a beta of 1.4, suggesting that its share price is 40% more volatile than the S&P 500. Does the media favor IPAR or CELH? In the previous week, Celsius had 25 more articles in the media than Interparfums. MarketBeat recorded 44 mentions for Celsius and 19 mentions for Interparfums. Celsius' average media sentiment score of 0.70 beat Interparfums' score of -0.04 indicating that Celsius is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Interparfums 4 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Celsius 18 Very Positive mention(s) 6 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is IPAR or CELH more profitable? Interparfums has a net margin of 11.30% compared to Celsius' net margin of 8.40%. Celsius' return on equity of 42.12% beat Interparfums' return on equity.Company Net Margins Return on Equity Return on Assets Interparfums11.30% 17.62% 11.86% Celsius 8.40%42.12%10.05% Do insiders and institutionals believe in IPAR or CELH? 55.6% of Interparfums shares are owned by institutional investors. Comparatively, 61.0% of Celsius shares are owned by institutional investors. 43.7% of Interparfums shares are owned by company insiders. Comparatively, 2.6% of Celsius shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has stronger earnings & valuation, IPAR or CELH? Interparfums has higher revenue and earnings than Celsius. Interparfums is trading at a lower price-to-earnings ratio than Celsius, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInterparfums$1.45B2.67$164.36M$5.1423.48Celsius$1.33B8.29$145.07M$0.32133.56 SummaryInterparfums beats Celsius on 9 of the 16 factors compared between the two stocks. Get Interparfums News Delivered to You Automatically Sign up to receive the latest news and ratings for IPAR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IPAR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IPAR vs. The Competition Export to ExcelMetricInterparfumsCONSM PD IndustryDiscretionary SectorNASDAQ ExchangeMarket Cap$3.88B$2.30B$8.10B$9.55BDividend Yield2.67%4.52%3.22%4.14%P/E Ratio23.4819.4219.2223.91Price / Sales2.672.044.6095.15Price / Cash19.6117.0316.4358.35Price / Book4.101.634.525.62Net Income$164.36M$103.54M$218.40M$265.35M7 Day Performance-1.71%-3.28%-0.46%-0.89%1 Month Performance-12.87%-6.58%38.18%4.98%1 Year Performance-7.37%-13.47%25.16%23.50% Interparfums Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IPARInterparfums4.3159 of 5 stars$120.68+1.8%$162.00+34.2%-7.4%$3.88B$1.45B23.48530News CoverageEarnings ReportDividend AnnouncementCELHCelsius3.5457 of 5 stars$45.18+1.0%$47.83+5.9%+3.4%$11.64B$1.36B141.191,073Insider TradeAnalyst RevisionCOTYCoty4.4962 of 5 stars$4.76+0.5%$7.80+64.0%-47.9%$4.15B$6.12B-9.9111,791ELFe.l.f. Beauty4.5637 of 5 stars$116.34-0.1%$123.94+6.5%-37.5%$6.60B$1.31B60.28300Trending NewsEarnings ReportLWLamb Weston4.7321 of 5 stars$54.63-2.4%$67.40+23.4%-5.8%$7.61B$6.45B21.7710,100Positive NewsMEDMedifast4.0941 of 5 stars$13.50-1.8%$16.50+22.2%-37.3%$148.37M$602.46M-20.77870News CoverageEarnings ReportNUSNu Skin Enterprises3.3301 of 5 stars$8.32+1.4%$6.88-17.3%-18.3%$410.84M$1.73B-10.393,100News CoverageUpcoming EarningsGap UpPOSTPost4.307 of 5 stars$105.19-0.3%$130.00+23.6%-7.2%$5.86B$7.92B18.7211,480Trending NewsUpcoming EarningsPBHPrestige Consumer Healthcare4.1061 of 5 stars$74.26+0.7%$93.33+25.7%+9.6%$3.67B$1.14B17.31540News CoverageUpcoming EarningsHLFHerbalife4.1511 of 5 stars$9.56+4.6%$11.50+20.2%-1.1%$974.09M$4.99B3.498,600News CoveragePositive NewsUSNAUSANA Health Sciences4.2847 of 5 stars$29.11+0.8%$36.00+23.7%-26.1%$542.02M$876.24M16.171,700 Related Companies and Tools Related Companies CELH Competitors COTY Competitors ELF Competitors LW Competitors MED Competitors NUS Competitors POST Competitors PBH Competitors HLF Competitors USNA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IPAR) was last updated on 8/6/2025 by MarketBeat.com Staff From Our Partners[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredGuess Who the Gvt Could Partner With Next?The Government Just Made a $400M Bet. Who's Next? A $100 trillion wealth shift is quietly underway... and t...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | SponsoredInstant Cash (every 3rd Monday)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Interparfums, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Interparfums With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IPAR Stock Alerts